Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
1 other identifier
interventional
80
1 country
1
Brief Summary
The estrogenic deficit characteristic of the climacteric stage is accompanied by a high incidence of health problems, such as the presence of Metabolic Syndrome risk factors that contribute to the increase of cardiovascular diseases. Objective: To determine the effect of a nursing intervention based on self-care aimed at improving the control of two metabolic syndrome risk factors (abdominal obesity and arterial hypertension) and health-related quality of life in climacteric women. Material and methods: Quasi-experimental study, non-equivalent control group design with women between 40 and 59 years old who present two risk factors of the Metabolic Syndrome (abdominal obesity and arterial hypertension) from two type C Health Centers of District 17D03 of Quito, Ecuador. Among one of the conceptual hypotheses, the researchers have Conceptual hypothesis 1: Climacteric women of the experimental group after the intervention of Nursing based on self-care improve two risk factors of MS with respect to those of the comparison group. A sample of 40 women was selected for experimental group and 40 for comparison group. Instruments and measurements: Abdominal Circumference, Blood Pressure, Menopause Rating Scale, International Physical Activity Questionnaire (IPAQ). Women in both groups received the usual care and those in the experimental group received a Nursing Intervention with technological support that included individual face-to-face nursing counseling, group education and physical activity sessions through a virtual platform for 12 weeks. Ethical requirements were considered. Expected results: It is expected that after the Nursing Intervention based on self-care the women of the experimental group will decrease the parameters of abdominal circumference, blood pressure and improve health-related quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 11, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2021
CompletedFirst Submitted
Initial submission to the registry
May 9, 2022
CompletedFirst Posted
Study publicly available on registry
May 24, 2022
CompletedMay 27, 2022
May 1, 2022
7 days
May 9, 2022
May 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in abdominal obesity
Anthropometric measurements (abdominal circumference)
Until the end of the study (3 months duration)
Reduce systolic and diastolic blood pressure
Vital sign (systolic and diastolic blood pressure)
Until the end of the study (3 months duration)
Improve health-related quality of life
Instrument Menopause Rating Scale: (Minimum total value "0 points" and maximum "44 points", if the score is higher the result is negative)
Until the end of the study (3 months duration)
Secondary Outcomes (1)
Increase the level of physical activity
Until the end of the study (3 months duration)
Study Arms (2)
Experimental group nursing intervention with technological support
EXPERIMENTALExperimental group composed of 40 with the same characteristics as above and attending the San Antonio de Pichincha Health Center, this group will additionally receive a nursing intervention of 3 months, to reduce the risk factors of MS and improve the quality of life related to health. The nursing intervention with web application support will consist of three elements: Individual face-to-face individual Nursing Counseling, Group Education and Physical Activity sessions through virtual platform.
Group compared regular care at the MSP Health Center
NO INTERVENTIONComparison group composed of 40 women in the climacteric stage between 40 and 59 years old who have two risk factors of MS (abdominal obesity and arterial hypertension), who go to the Health Center of the People's Committee, to the group of the Hypertensive Program that receive the usual attention of the Institution on group talks, health fairs based on general topics of the disease.
Interventions
Nursing intervention with technological support (Metamorphosis) in two risk factors of Metabolic Syndrome, abdominal obesity and hypertension and quality of life in the climacteric period, developed in 3 months, in the experimental group that includes individual nursing counseling, group education virtually and physical activity sessions for 12 weeks virtually.
Eligibility Criteria
You may qualify if:
- Be between 40 and 59 years of age.
- Abdominal circumference equal to or greater than 80 cm.
- Blood pressure equal to or greater than 130/85mmHg or on antihypertensive treatment
- Being able to ambulate without assistance.
- Population residing in the sector in which you are registered.
- Access to mobile or fixed internet service.
You may not qualify if:
- Women on hormone replacement therapy.
- Women with hysterectomy and/or oophorectomy
- Pregnant women.
- Women with cardiovascular disease such as dyslipidemia, type II diabetes; cancer; hypothyroidism; respiratory disease; neuromuscular or terminal illness.
- People who cannot read or write.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad de Concepcionlead
- Universidad Central del Ecuadorcollaborator
Study Sites (1)
Centro de Salud de San Antonio de Pichincha
Quito, Pichincha, 593, Ecuador
Related Publications (41)
Wang CH, Chung MH, Chan P, Tsai JC, Chen FC. Effects of endurance exercise training on risk components for metabolic syndrome, interleukin-6, and the exercise capacity of postmenopausal women. Geriatr Nurs. 2014 May-Jun;35(3):212-8. doi: 10.1016/j.gerinurse.2014.02.001. Epub 2014 Mar 26.
PMID: 24679550RESULTLin CH, Chiang SL, Heitkemper MM, Hung YJ, Lee MS, Tzeng WC, Chiang LC. Effects of telephone-based motivational interviewing in lifestyle modification program on reducing metabolic risks in middle-aged and older women with metabolic syndrome: A randomized controlled trial. Int J Nurs Stud. 2016 Aug;60:12-23. doi: 10.1016/j.ijnurstu.2016.03.003. Epub 2016 Mar 12.
PMID: 27297365RESULTChiang LC, Heitkemper MM, Chiang SL, Tzeng WC, Lee MS, Hung YJ, Lin CH. Motivational Counseling to Reduce Sedentary Behaviors and Depressive Symptoms and Improve Health-Related Quality of Life Among Women With Metabolic Syndrome. J Cardiovasc Nurs. 2019 Jul/Aug;34(4):327-335. doi: 10.1097/JCN.0000000000000573.
PMID: 30920439RESULTVilchez Barboza V, Klijn TP, Salazar Molina A, Saez Carrillo KL. Effectiveness of personalized face-to-face and telephone nursing counseling interventions for cardiovascular risk factors: a controlled clinical trial. Rev Lat Am Enfermagem. 2016 Aug 8;24:e2747. doi: 10.1590/1518-8345.0626.2747.
PMID: 27508917RESULTYusuf S, Wood D, Ralston J, Reddy KS. The World Heart Federation's vision for worldwide cardiovascular disease prevention. Lancet. 2015 Jul 25;386(9991):399-402. doi: 10.1016/S0140-6736(15)60265-3. Epub 2015 Apr 16. No abstract available.
PMID: 25892680RESULTChedraui P, Perez-Lopez FR, Mendoza M, Morales B, Martinez MA, Salinas AM, Hidalgo L. Severe menopausal symptoms in middle-aged women are associated to female and male factors. Arch Gynecol Obstet. 2010 May;281(5):879-85. doi: 10.1007/s00404-009-1204-z. Epub 2009 Aug 14.
PMID: 19680673RESULTHayman LL, Berra K, Fletcher BJ, Houston Miller N. The Role of Nurses in Promoting Cardiovascular Health Worldwide: The Global Cardiovascular Nursing Leadership Forum. J Am Coll Cardiol. 2015 Aug 18;66(7):864-866. doi: 10.1016/j.jacc.2015.06.1319. No abstract available.
PMID: 26271070RESULTGoncalves JT, Silveira MF, Campos MC, Costa LH. Overweight and obesity and factors associated with menopause. Cien Saude Colet. 2016 Apr;21(4):1145-56. doi: 10.1590/1413-81232015214.16552015. English, Portuguese.
PMID: 27076013RESULTNunez-Pizarro JL, Gonzalez-Luna A, Mezones-Holguin E, Blumel JE, Baron G, Bencosme A, Benitez Z, Bravo LM, Calle A, Flores D, Espinoza MT, Gomez G, Hernandez-Bueno JA, Martino M, Lima S, Monterrosa A, Mostajo D, Ojeda E, Onatra W, Sanchez H, Tserotas K, Vallejo MS, Witis S, Zuniga MC, Chedraui P. Association between anxiety and severe quality-of-life impairment in postmenopausal women: analysis of a multicenter Latin American cross-sectional study. Menopause. 2017 Jun;24(6):645-652. doi: 10.1097/GME.0000000000000813.
PMID: 28118294RESULTShin H, Shin HS. Measurement of quality of life in menopausal women: a systematic review. West J Nurs Res. 2012 Jun;34(4):475-503. doi: 10.1177/0193945911402848. Epub 2011 Mar 25.
PMID: 21441417RESULTSayan S, Pekin T, Yildizhan B. Relationship between vasomotor symptoms and metabolic syndrome in postmenopausal women. J Int Med Res. 2018 Oct;46(10):4157-4166. doi: 10.1177/0300060518790709. Epub 2018 Aug 9.
PMID: 30092678RESULTZajac-Gawlak I, Klapcinska B, Kroemeke A, Pospiech D, Pelclova J, Pridalova M. Associations of visceral fat area and physical activity levels with the risk of metabolic syndrome in postmenopausal women. Biogerontology. 2017 Jun;18(3):357-366. doi: 10.1007/s10522-017-9693-9. Epub 2017 Mar 18.
PMID: 28316012RESULTMontez JK, Bromberger JT, Harlow SD, Kravitz HM, Matthews KA. Life-Course Socioeconomic Status and Metabolic Syndrome Among Midlife Women. J Gerontol B Psychol Sci Soc Sci. 2016 Nov;71(6):1097-1107. doi: 10.1093/geronb/gbw014. Epub 2016 Feb 28.
PMID: 26926957RESULTChedraui P, Aguirre W, Hidalgo L, Fayad L. Assessing menopausal symptoms among healthy middle aged women with the Menopause Rating Scale. Maturitas. 2007 Jul 20;57(3):271-8. doi: 10.1016/j.maturitas.2007.01.009. Epub 2007 Feb 27.
PMID: 17329046RESULTGiannouli P, Zervas I, Armeni E, Koundi K, Spyropoulou A, Alexandrou A, Kazani A, Areti A, Creatsa M, Lambrinoudaki I. Determinants of quality of life in Greek middle-age women: a population survey. Maturitas. 2012 Feb;71(2):154-61. doi: 10.1016/j.maturitas.2011.11.013. Epub 2011 Dec 16.
PMID: 22177978RESULTRaczkiewicz D, Owoc A, Wierzbinska-Stepniak A, Bojar I. Metabolic syndrome in peri - and postmenopausal women performing intellectual work. Ann Agric Environ Med. 2018 Dec 20;25(4):610-615. doi: 10.26444/aaem/74451. Epub 2017 Jul 13.
PMID: 30586981RESULTLee WJ, Yoon JW, Lee JH, Kwag BG, Chang SH, Choi YJ. Effects of Age at First Childbirth and Other Factors on Central Obesity in Postmenopausal Women: The 2013-2015 Korean National Health and Nutrition Examination Survey. Korean J Fam Med. 2018 May;39(3):155-160. doi: 10.4082/kjfm.2018.39.3.155. Epub 2018 May 18.
PMID: 29788703RESULTKim HR, Kim HS. Optimal Cutoffs of Cardiometabolic Risk for Postmenopausal Korean Women. Asian Nurs Res (Korean Soc Nurs Sci). 2017 Jun;11(2):107-112. doi: 10.1016/j.anr.2017.05.003. Epub 2017 Jun 1.
PMID: 28688495RESULTTsai SS, Lin YS, Hwang JS, Chu PH. Vital roles of age and metabolic syndrome-associated risk factors in sex-specific arterial stiffness across nearly lifelong ages: Possible implication of menopause and andropause. Atherosclerosis. 2017 Mar;258:26-33. doi: 10.1016/j.atherosclerosis.2017.01.023. Epub 2017 Jan 20.
PMID: 28182996RESULTMozos I, Malainer C, Horbanczuk J, Gug C, Stoian D, Luca CT, Atanasov AG. Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases. Front Immunol. 2017 Aug 31;8:1058. doi: 10.3389/fimmu.2017.01058. eCollection 2017.
PMID: 28912780RESULTMiguel-Soca PE, Rivas-Estevez M, Sarmiento-Teruel Y, Marino-Soler AL, Marrero-Hidalgo M, Mosqueda-Batista L, Pena-Perez I, Rivas-Vazquez D, Llorente-Columbie Y. Prevalence of Metabolic Syndrome Risk Factors in Adults in Holguin, Cuba (2004-2013). MEDICC Rev. 2016 Jan-Apr;18(1-2):28. doi: 10.37757/MR2016.V18.N1-2.6. Epub 2016 May 10. No abstract available.
PMID: 34362239RESULTGo AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21;129(3):e28-e292. doi: 10.1161/01.cir.0000441139.02102.80. Epub 2013 Dec 18. No abstract available.
PMID: 24352519RESULTAleyasin SA, Navidi T, Davoudi S. Association between rs10757274 and rs2383206 SNPs as Genetic Risk Factors in Iranian Patients with Coronary Artery Disease. J Tehran Heart Cent. 2017 Jul;12(3):114-118.
PMID: 29062378RESULTHwang YS, Park EJ, Choi JG, Kim HE, Park SG, Yoo SM. Relationship between Age at Menarche and Metabolic Syndrome in Premenopausal Women: Korea National Health and Nutrition Examination Survey 2013-2014. Korean J Fam Med. 2018 Sep;39(5):300-306. doi: 10.4082/kjfm.17.0022. Epub 2018 Jul 30.
PMID: 30056694RESULTSciomer S, Moscucci F, Dessalvi CC, Deidda M, Mercuro G. Gender differences in cardiology: is it time for new guidelines? J Cardiovasc Med (Hagerstown). 2018 Dec;19(12):685-688. doi: 10.2459/JCM.0000000000000719.
PMID: 30239478RESULTDavis SR, Lambrinoudaki I, Lumsden M, Mishra GD, Pal L, Rees M, Santoro N, Simoncini T. Menopause. Nat Rev Dis Primers. 2015 Apr 23;1:15004. doi: 10.1038/nrdp.2015.4.
PMID: 27188659RESULTBentley-Lewis R, Koruda K, Seely EW. The metabolic syndrome in women. Nat Clin Pract Endocrinol Metab. 2007 Oct;3(10):696-704. doi: 10.1038/ncpendmet0616.
PMID: 17893688RESULTOh GC, Kang KS, Park CS, Sung HK, Ha KH, Kim HC, Park S, Ihm SH, Lee HY. Metabolic syndrome, not menopause, is a risk factor for hypertension in peri-menopausal women. Clin Hypertens. 2018 Oct 15;24:14. doi: 10.1186/s40885-018-0099-z. eCollection 2018.
PMID: 30349737RESULTKozakowski J, Gietka-Czernel M, Leszczynska D, Majos A. Obesity in menopause - our negligence or an unfortunate inevitability? Prz Menopauzalny. 2017 Jun;16(2):61-65. doi: 10.5114/pm.2017.68594. Epub 2017 Jun 30.
PMID: 28721132RESULTMattei J, Tamez M, Rios-Bedoya CF, Xiao RS, Tucker KL, Rodriguez-Orengo JF. Health conditions and lifestyle risk factors of adults living in Puerto Rico: a cross-sectional study. BMC Public Health. 2018 Apr 12;18(1):491. doi: 10.1186/s12889-018-5359-z.
PMID: 29650018RESULTSabanovic S, Ljiljana MT, Babic F, Vadovsky M, Paralic J, Vcev A, Holzinger A. Metabolic syndrome in hypertensive women in the age of menopause: a case study on data from general practice electronic health records. BMC Med Inform Decis Mak. 2018 Apr 2;18(1):24. doi: 10.1186/s12911-018-0601-2.
PMID: 29609615RESULTYeh ML, Liao RW, Hsu CC, Chung YC, Lin JG. Exercises improve body composition, cardiovascular risk factors and bone mineral density for menopausal women: A systematic review and meta-analysis of randomized controlled trials. Appl Nurs Res. 2018 Apr;40:90-98. doi: 10.1016/j.apnr.2017.12.011. Epub 2017 Dec 19.
PMID: 29579505RESULTOh EG, Bang SY, Kim SH, Hyun SS, Chu SH, Jeon JY, Im JA, Lee JE, Lee MK. Therapeutic lifestyle modification program reduces plasma levels of the chemokines CRP and MCP-1 in subjects with metabolic syndrome. Biol Res Nurs. 2013 Jan;15(1):48-55. doi: 10.1177/1099800411416637. Epub 2011 Aug 22.
PMID: 21859748RESULTOh EG, Hyun SS, Kim SH, Bang SY, Chu SH, Jeon JY, Kang MS. A randomized controlled trial of therapeutic lifestyle modification in rural women with metabolic syndrome: a pilot study. Metabolism. 2008 Feb;57(2):255-61. doi: 10.1016/j.metabol.2007.09.009.
PMID: 18191057RESULTBeckie TM, Beckstead JW, Groer MW. The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease. J Cardiovasc Nurs. 2010 Jan-Feb;25(1):52-60. doi: 10.1097/JCN.0b013e3181b7e500.
PMID: 19935427RESULTTaylor JY, Wu CY. Effects of genetic counseling for hypertension on changes in lifestyle behaviors among African-American women. J Natl Black Nurses Assoc. 2009 Jul;20(1):1-10.
PMID: 19691178RESULTWilliams LT, Hollis JL, Collins CE, Morgan PJ. The 40-Something randomized controlled trial to prevent weight gain in mid-age women. BMC Public Health. 2013 Oct 25;13:1007. doi: 10.1186/1471-2458-13-1007.
PMID: 24156558RESULTWilliams LT, Hollis JL, Collins CE, Morgan PJ. Can a relatively low-intensity intervention by health professionals prevent weight gain in mid-age women? 12-Month outcomes of the 40-Something randomised controlled trial. Nutr Diabetes. 2014 May 5;4(5):e116. doi: 10.1038/nutd.2014.12.
PMID: 24799163RESULTLim H, Son JY, Choue R. Effects of medical nutrition therapy on body fat and metabolic syndrome components in premenopausal overweight women. Ann Nutr Metab. 2012;61(1):47-56. doi: 10.1159/000339262. Epub 2012 Jul 20.
PMID: 22832546RESULTBlumenthal JA, Babyak MA, Sherwood A, Craighead L, Lin PH, Johnson J, Watkins LL, Wang JT, Kuhn C, Feinglos M, Hinderliter A. Effects of the dietary approaches to stop hypertension diet alone and in combination with exercise and caloric restriction on insulin sensitivity and lipids. Hypertension. 2010 May;55(5):1199-205. doi: 10.1161/HYPERTENSIONAHA.109.149153. Epub 2010 Mar 8.
PMID: 20212264RESULTChedraui P, Blumel JE, Baron G, Belzares E, Bencosme A, Calle A, Danckers L, Espinoza MT, Flores D, Gomez G, Hernandez-Bueno JA, Izaguirre H, Leon-Leon P, Lima S, Mezones-Holguin E, Monterrosa A, Mostajo D, Navarro D, Ojeda E, Onatra W, Royer M, Soto E, Tserotas K. Impaired quality of life among middle aged women: a multicentre Latin American study. Maturitas. 2008 Dec 20;61(4):323-9. doi: 10.1016/j.maturitas.2008.09.026. Epub 2008 Nov 17.
PMID: 19010618RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sandra C Riofrío Terrazas, Dra (c)
Universidad Central del Ecuador
- STUDY CHAIR
Sandra C Riofrío Terrazas, Dra (c)
Centro de Salud San Antonio de Pichincha
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Masking Details
- As blinding is an unavoidable condition in this type of study, the surveyors in the data collection will not have knowledge about the experimental group and comparison group, so they will be given as group A and B, both at the beginning and at the end of the study in the pre- and post-tests, with the aim of preventing certain biases in some of the stages of the trial and thus protect the sequence after the allocation for convenience.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Director
Study Record Dates
First Submitted
May 9, 2022
First Posted
May 24, 2022
Study Start
September 4, 2021
Primary Completion
September 11, 2021
Study Completion
December 22, 2021
Last Updated
May 27, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share